Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berglind Adalsteinsdottir

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Allergology International : Official Journal of the Japanese Society of Allergology|January 30, 2007
What characterizes house dust mite sensitive individuals in a house dust mite free community in Reykjavik, Iceland?Berglind Adalsteinsdottir, Sigurveig Th Sigurdardottir, Thorarinn Gislason, et al.
Open Heart|April 29, 2020
Hypertrophic cardiomyopathy in myosin-binding protein C (<i>MYBPC3</i>) Icelandic founder mutation carriersBerglind Adalsteinsdottir, Michael Burke, Barry J Maron, et al.
Circulation|August 1, 2014
Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutationBerglind Adalsteinsdottir, Polakit Teekakirikul, Barry J Maron, et al.
European Heart Journal|March 29, 2018
A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aortaThorsteinn Bjornsson, Rosa B Thorolfsdottir, Gardar Sveinbjornsson, et al.
Circulation. Cardiovascular Genetics|August 12, 2017
Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset PhenotypesBerglind Adalsteinsdottir, Runolfur Palsson, Robert J Desnick, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Allergology International : Official Journal of the Japanese Society of Allergology|January 30, 2007
What characterizes house dust mite sensitive individuals in a house dust mite free community in Reykjavik, Iceland?Berglind Adalsteinsdottir, Sigurveig Th Sigurdardottir, Thorarinn Gislason, et al.
Open Heart|April 29, 2020
Hypertrophic cardiomyopathy in myosin-binding protein C (<i>MYBPC3</i>) Icelandic founder mutation carriersBerglind Adalsteinsdottir, Michael Burke, Barry J Maron, et al.
Circulation|August 1, 2014
Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutationBerglind Adalsteinsdottir, Polakit Teekakirikul, Barry J Maron, et al.
European Heart Journal|March 29, 2018
A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aortaThorsteinn Bjornsson, Rosa B Thorolfsdottir, Gardar Sveinbjornsson, et al.
Circulation. Cardiovascular Genetics|August 12, 2017
Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset PhenotypesBerglind Adalsteinsdottir, Runolfur Palsson, Robert J Desnick, et al.
Pageof 1